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Abstract 
The tertiary structure of proteinaceous protease inhibitors is considered to be maintained by various interactions in the molecule that 
prevent degradation by protease. In this study, the Arg29 of Streptomyces subtilisin inhibitor (SSI) forming a salt bridge with 
the carboxyl group of carboxyl-terminal Phe”’ was replaced with Ala, Met or Lys by cassette mutagenesis to clarify the role of Arti in the function 
of SSI. The inhibitory activity of each mutated SSI decreased with increasing incubation time after mixing with subtilisin, indicating that the SSI 
was changed into a temporary inhibitor upon mutation. This decrease was shown by SDS polyacrylamide gel electrophoresis to be due to cooperative 
degradation of the mutated SSI by subtilisin. In addition, the denaturation temperature of the Ala or Met mutant was decreased by ten degrees and 
that of the Lys mutant by 1.5 degrees, suggesting that the destabilization of SSI may be related to its temporary inhibition. Thus, interaction in the 
protease inhibitor molecule for maintaining the tertiary structure, such as that of A$ in SSI, was shown to be required for the inhibitory action. 
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1. Introduction 
Structure-function relationship studies on serine 
protease inhibitors including Streptomyces ubtilisin 
inhibitor (SSI) have shown that the local structure 
around the reactive site resembles that of the substrate, 
and thus the amino acid residue at the Pl site of the 
inhibitor determines the specificity toward protease [l- 
61. Previously, we have succeeded in alterating the inhib- 
itory specificity of SSI by replacing the amino acid 
residue at the Pl site [6]. Protein protease inhibitors of 
relatively small size, such as SSI and bovine pancreatic 
trypsin inhibitor, inhibit protease by forming a stable 
Michaelis complex without cleavage of the peptide bond 
at the reactive site [1,2]. However, it is not clear why 
protease inhibitors having a substrate-like structure are 
not degraded by cognate protease. In an attempt to ad- 
dress this issue, we have been investigating the structural 
features of SSI that are necessary for its inhibitory ac- 
tion. 
In this study, we focused on the salt bridge between the 
positive charge of the Arg2’ guanidino group and the 
negative charge of the carboxyl-terminal Phe’13 carboxyl 
group [7] for the following reasons. Sakai et al. have 
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reported that SSI is converted to a temporary inhibitor 
when the four carboxyl-terminal amino acid residues 
(Val-Phe-Thr-Phe) in the hydrophobic core are released 
from SSI by treatment with carboxypeptidase A [8]. 
The release of these four residues includes the loss of 
the salt bridge between the terminal carboxylate and 
the guanidino group of A$‘. Therefore, it is import- 
ant to clarify whether the temporary inhibition exhibited 
by SSI lacking these four residues is due to the loss of the 
salt bridge or the release of the four residues in the 
hydrophobic core. In addition, the Argzv residue is con- 
served in all members of the SSI family of protease inhib- 
itors isolated from Streptomyces [9,10], and its impor- 
tance for the function of SSI as an inhibitor has been 
suggested. 
Therefore, we substituted Arg2’ with other amino 
acids to destroy the salt bridge between Ar$’ and the 
carboxyl terminus, and examined the effects of these 
substitutions on the inhibitory action and stability of 
SSI. 
2. Materials and methods 
2. I Materials 
Restriction enzymes and DNA-modifying enzymes were purchased 
from Toyobo and Boehringer Mannheim. Subtilisin BPN’ and casein 
(Hammersten) were obtained from Nagase Biochemicals and Merck, 
respectively. All other chemicals were of the best grade available for 
biochemical research. 
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2.2. Cassette mutagenesis of the SSI gene 
We constructed a new plasmid for codon substitution of Arg” 
(CGC). A SmaI-Auf11 fragment (210 bp) corresponding to the coding 
region of Pro(-2)-Val@ of SSI was isolated from an SSI-encoding plas- 
mid, pSI52, and inserted into the SmaI-AatII site of pUC18. The result- 
ing plasmid pSISA containing the Argz9 codon was used for cassette 
mutation. Fig. 1 shows a schematic representation of cassette mut- 
agenesis. pSISA was digested with BstEII and AvaI. The AvaI-BstEII 
small fragment was then digested with @aI1 to remove the region 
containing Arg 29 The two synthetic oligonucleotides shown in Fig. 1 . 
were designed as a mixture of twelve species in order to introduce Lys, 
Met and Ala into the position of Arg2!‘. The AvaI-BstEII large fragment 
of pSISA, the AvuI-HpaII small fragment of pSISA, and the annealed 
oligonucleotides were ligated, and the resulting DNA was transferred 
into Escherichiu coli JM109. Screening of E. coli harboring the mutated 
pSISA was carried out by colony hybridization using the following 
synthetic oligonucleotides: 
*** 
5 ‘ACCGGAAAAGGCGGTCA3 ’ for Lys, 
*** 
5 ‘ACCGGAAATGGCGGTCA3 ’ for Met, 
*** 
5 ‘ACCGGAAGCCGCGGTCA3 ’ for Ala 
(asterisks indicate the codon at position 29). The mutations were veri- 
fied by dideoxy sequencing of the plasmid using a ‘reverse’ primer. 
2.3. Expression of the mutated SSIgene andpurification of mutated SSIs 
Mutated pSISA was digested with SmaI and A&II, and the small 
fragment containing the SSI gene was inserted into the SmuI-A&II site 
of pSIML containing a minimal fragment of the SSI gene sufficient for 
its expression [ll]. The mutated SSI gene was ligated with streptomy- 
cete plasmid pIJ702 at the SucI-SphI sites. Sfreptomyces lividuns 66 was 
transformed with the resulting plasmid using thiopeptin as an antibiotic 
marker. The secreted mutated SSIs were purified from the culture broth 
of S. lividuns 66 by ammonium sulfate precipitation and three steps of 
chromatography: ion-exchange chromatography on DE-32 and gel- 
filtration on Sephacryl S-200, as described previously [6], and hydro- 
phobic chromatography on Phenyl-Sepharose. The concentrations of 
SSIs were estimated from the molar absorbance coefficient of wild-type 
SSI [12]. 
2.4. Other analytical methods 
Measurements of the inhibitory activity of mutated SSIs toward 
subtilisin BPN’ and its dependency on incubation time, circular di- 
chroism measurements and SDS polyacrylamide gel electrophoresis 
were carried out by the same procedures as those described previously 
[6,11,13]. Details of these measurements are given in the figure legends. 
3. Results 
3.1. Inhibition of subtilisin BPN’ by the mutated SSIs 
The inhibitory profiles of the mutated SSIs, in which 
the Arg?g residue was convgrted to Lys, Met or Ala, 
toward subtilisin BPN’ are shown in Fig. 2, together with 
that of the wild-type SSI. When the molar ratio of SSI 
to subtilisin was larger than one, the inhibitory activity 
of wild-type SSI did not decrease with incubation time 
after mixing of SSI with protease. However, under the 
same conditions, the inhibitory activity of each mutated 
SSI was found to decrease with increasing incubation 
time. This is the characteristic of temporary inhibition. 
Among the three mutant forms of SSI, the rate of de- 
crease in ‘the inhibitory activity was fastest for the Ala 
mutant, and slowest for the Lys mutant. These results 
indicate that Arg2’ is required for the inhibitory action 
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Fig. 1. Schematic representation of plasmid construction for cassette 
mutagenesis of Ar$9. The AvaI-BstEII large fragment and AvaI-HpaII 
small fragment were isolated from the plasmid pSISA, which contains 
the amino-terminal half of the SSI gene, and then ligated with annealed 
synthetic oligonucleotides, which were designed so as to introduce Ala, 
Met and Lys into position 29 of SSI. The mutated gene containing each 
mutation was then screened by colony hybridization. 
of SSI, and that substitution with other residues converts 
SSI to a temporary inhibitor. 
3.2. SDS-polyacrylamide gel electrophoretic analysis of 
subtilisin-mutated SSI complex 
In order to examine whether the temporary inhibition 
produced by these mutated SSIs was due to their degra- 
dation, SDS polyacrylamide gel electrophoresis was car- 
ried out. Fig. 3 shows the electrophoretic patterns of 
mixtures of subtilisin and the mutated SS% after various 
incubation times. The bands of the mutated SSIs were 
found to fade with increasing incubation time after mix- 
ing with subtilisin. Initially, the amino-terminal region 
(to Leu6) of SSI was degraded, and this species appeared 
as a faster-migrating band on SDS-PAGE. Amino-ter- 
minal shortening, which is also observed for wild-type 3. 
SSI, was shown not to affect the inhibitory property of 
the SSIs, and thus was not directly related to temporary 
inhibition. Then, the shortened SSI was additionally de- 
graded by subtilisin without any intermediate species, 
suggesting that the degradation was cooperative. Among 
the three mutants, the degradation rate of the Ala mutant 
was the fastest, and that of the Lys mutant the slowest. 
This order was the same as that for the inhibitory activity. 
3.3. Thermal stability of mutated SSIs measured by circu- 
lar dichroism (CD) 
The CD spectra of the mutant SSIs at room tempera- 
ture were the same as that of the wild-type SSI (data not 
shown), indicating the correct folding of each mutant. 
Then, the thermostability of the mutant SSIs was investi- 
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Fig. 2. Time dependence of inhibitory activities of SSI(29A) (A), 
SSI(29M) (B), SSI(29K) (C) and wild-type SSI (D) toward caseinolytic 
activity of subtilisin BPN’. At 0 min (o), 10 min (A), 30 min (m) and 60 
min (v) of incubation at 37°C after mixing subtilisin (364 nM) with 
various amounts of SSI, an aliquot (100~1) containing4pg of subtilisin 
was withdrawn, and the inhibitory activity was measured using 1% 
casein as a substrate. 
Incubation R29A R29M R29K Wild- type 
Fig. 3. SDS polyacrylamide gel electrophoresis of mixtures of mutant 
SSIs and subtilisin BPN’ after incubation for various times. Equimolar 
amounts of subtilisin and each mutated SSI were mixed and incubated 
at 37°C in 0.1 M borate buffer (pH 9.5). At each time, a 100~~1 aliquot 
containing 4pg of subtilisin, was withdrawn. Proteins were precipitated 
with trichloroacetic acid at a final concentration of 68, and then sub- 
jected to SDS-polyacrylamide gel electrophoresis (gel concentration 
18.8%). 
gated by carrying out measurements at increasing tem- 
perature. CD intensity (218 nm) at various temperatures 
was plotted as a value relative to that at 30°C (Fig. 4). 
T,,* (defined as the temperature at which the midpoint 
of decreasing intensity occurs) of wild-type SSI was 
78°C and conversion of Arg2’ to Lys lowered T,,* by 
15°C (76.5”C). T,,2 of mutated SSIs in which A$’ was 
substituted with Met or Ala was 68°C indicating a 10°C 
decrease in thermal stability. These observations uggest 
that the positive charge at position 29 is also required for 
l.O- 0 
30 40 50 60 70 80 90 
Temperature (“C) 
Fig. 4. Temperature dependency of CD intensity of mutated (a = Ala, 
q = Met, v = Lys) and wild-type SSIs (0) at 218 nm. CD intensities 
were measured at a concentration of 100 &ml in 50 mM phosphate 
buffer (pH 7.0) and are represented as values relative to that at 30°C. 
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the stability of SSI through interaction with the negative 
charge at the carboxyl-terminus. 
4. Discussion 
Protein protease inhibitors have the unique property 
of resisting degradation by proteases despite having a 
structure around their reactive site which is similar to 
that of a substrate. Therefore, it is likely that the molec- 
ular structure of protease inhibitors includes some char- 
acteristic features that confer resistance to degradation. 
We have therefore been searching for the structural re- 
quirements of SSI that enable it to function as an inhib- 
itor, in expectation that this help to elucidate the mecha- 
nism of the inhibitory action. 
Ar$9, the residue substituted in the present study, was 
chosen on the basis of information obtained by X-ray 
crystallographic analysis [7], an enzymatic modification 
study using carboxypeptidase A [8] and its degree of 
conservation in closely related protease inhibitors [9,10]. 
The Arg residue at position 29 was converted to Lys, Met 
or Ala. These residues were chosen in order to investigate 
the role of the positive charge and hydrophobic methyle- 
nes in the side chain of Arg. 
Replacement of Arg29 with Ala or Met resulted in 
conversion of SSI to a temporary inhibitor. Thus, the 
positive charge of Arg29 was found to be very important 
for the inhibitory action of SSI. Among the two SSI 
mutants (with Ala or Met at position 29), the rate of 
decrease of the inhibitory activity of the Ala mutant was 
faster than that of the Met mutant, indicating that hydro- 
phobic methylenes also contribute to structural mainte- 
nance of the SSI molecule, since X-ray crystallographic 
analysis has shown that the side chain of Arg29 is buried 
in the hydrophobic core. In addition, the temporary inhi- 
bition shown by even the Lys mutant carrying a positive 
charge demonstrates that the length of the side chain at 
position 29 is important for electrostatic interaction with 
a carboxyl group at the carboxyl-terminus, although the 
positive charge is more important. 
The fact that these position-29 mutants had inhibitory 
activity as strong as that of the wild type suggested that 
the structural change around their reactive site was 
small. However, since structural fluctuation may occur 
in the mutated SSI molecule, possibly due to reduction 
of the interaction with the carboxyl group at the carboxyl 
terminus by replacement of the Argz9 residue, mutated 
SSI was degraded by subtilisin. Furthermore, structural 
instability of the position-29 mutants was shown indi- 
rectly by the reduction of their thermal stability in terms 
of CD intensity at 218 nm. In other words, these mutants 
become easily denatured due to the loss of the electro- 
static interaction between Arg2’ and the carboxyl-termi- 
nus. Thus, it seems likely that this destabilization of SSIs 
is closely related to their temporary inhibition. Analysis 
of the other protease-sensitive SSI mutants also suggests 
a high correlation between destabilization and tempo- 
rary inhibition [ 1 I, 13,141. 
Two possibilities can be considered for the mechanism 
of temporary inhibition of mutated SSIs. One is that the 
denatured fraction, which is extremely small in the wild 
type, is increased by reduction of stability occurring 
upon mutation, and thus degradation of the mutant SSI 
proceeds via proteolytic attack toward the denatured 
form. This mechanism has been proven for the Trps6+ 
His mutant of SSI; TrpS6, which is located distant from 
the reactive site, was shown to contribute to the stability 
and function of SSI by reducing the denatured fraction 
[14]. This situation seems to resemble that in the present 
mutations. The other possible mechanism is that diges- 
tion occurs when the mutated SSI is in a complex with 
protease. In this case, the reactive site is digested initially, 
and a specific intermediate of SSI with only the reactive 
site cleaved is detected. This phenomenon has been ob- 
served in mutant SSIs in which the disulfide bridge near 
the reactive site [13] or two amino acid residues in the 
flexible loop near the reactive site were deleted [I I]. 
Therefore the structure of protease inhibitors enables 
them to resist proteolysis after binding with protease. 
With regard to the position-29 mutants, the former 
mechanism seems more likely, because: (i) the conforma- 
tional change around the reactive site is small, as in the 
case of Trp”+His, because the binding activity of the 
mutants did not change markedly, (ii) specific intermedi- 
ates such as reactive-site-cleaved species were not de- 
tected, and (iii) Arg29 is located relatively distant from 
the reactive site of SSI. 
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